Functional analysis of the hepatic HMG-CoA reductase promoter by in vivo electroporation

Experimental Biology and Medicine

Volumn 232, Issue 3, 2007, Pages 353-361

  Lagor, William R ^a   Heller, Richard ^a   De Groh, Eric D ^a   Ness, Gene C ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

HMGR promoter; in vivo electroporation; Liver

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MEVINOLIN; STEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALYSIS; CYCLIC AMP RESPONSIVE ELEMENT; DRUG EFFECT; DRUG MECHANISM; ELECTROPORATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; GENE DELETION; LIVER; LIVER CELL; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; RAT;

ANIMALS; CHOLESTEROL; ELECTROPORATION; GENE DELETION; GENE EXPRESSION REGULATION; HYDROXYMETHYLGLUTARYL COA REDUCTASES; LIVER; LOVASTATIN; LUCIFERASES; MALE; MICROSOMES, LIVER; MUTATION; PLASMIDS; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION;

ANIMALIA;

EID: 33847383291     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Ness GC, Gertz KR. Hepatic HMG-CoA reductase expression and resistance to dietary cholesterol. Exp Biol Med 229:412-416, 2004.
2. Tobert JA, Hitzenberger G, Kukovetz WR, Holmes IB, Jones KH. Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase. Atherosclerosis 41:61-65, 1982.
3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-1389, 1994.
4. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN; REVERSAL Investigators. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291:1071-1080, 2004.
5. Chasman DI, Posada D, Subrahmanyan L, Cook NR, Stanton VP, Jr., Ridker PM. Pharmacogenetic study of statin therapy and cholesterol reduction. JAMA 291:2821-2827, 2004.
6. Ness GC, Chambers CM. Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol buffering capacity. Proc Soc Exp Biol Med 224:8-19, 2000.
7. Osborne TF, Gil G, Brown MS, Kowal RC, Goldstein JL. Identification of promoter elements required for in vitro transcription of hamster 3-hydroxy-3-methylglutaryl coenzyme A reductase gene. Proc Natl Acad Sci U S A 84:3614-3618, 1987.
8. Osborne TF, Goldstein JL, Brown MS. 5′ end of HMG CoA reductase gene contains sequences responsible for cholesterol-mediated inhibition of transcription. Cell 42:203-212, 1985.
9. Osborne TF, Gil G, Goldstein JL, Brown MS. Operator constitutive mutation of 3-hydroxy-3-methylglutaryl coenzyme A reductase promoter abolishes protein binding to sterol regulatory element. J Biol Chem 263:3380-3387, 1988.
10. Osborne TF. Single nucleotide resolution of sterol regulatory region in promoter for 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Biol Chem 266:13947-13951, 1991.
11. Sudhof TC, Russell DW, Brown MS, Goldstein JL. 42 bp element from LDL receptor gene confers end-product repression by sterols when inserted into viral TK promoter. Cell 48:1061-1069, 1987.
12. Metherall JE, Goldstein JL, Luskey KL, Brown MS. Loss of transcriptional repression of three sterol-regulated genes in mutant hamster cells. J Biol Chem 264:15634-15641, 1989.
13. Bennett MK, Osborne TF. Nutrient regulation of gene expression by the sterol regulatory element binding proteins: increased recruitment of gene-specific coregulatory factors and selective hyperacetylation of histone H3 in vivo. Proc Natl Acad Sci U S A 97:6340-6344, 2000.
14. Bifulco M, Perillo B, Saji M, Laezza C, Tedesco I, Kohn LD and Aloj SM. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in FRTL-5 cells. I. Identification and characterization of a cyclic AMP-responsive element in the rat reductase promoter. J Biol Chem 270:15231-15236, 1995.
15. Datta S, Wang L, Moore DD, Osborne TF. Regulation of 3-hydroxy-3- methylglutaryl coenzyme A reductase promoter by nuclear receptors liver receptor homologue-1 and small heterodimer partner: a mechanism for differential regulation of cholesterol synthesis and uptake. J Biol Chem 281:807-812, 2006.
16. Hua X, Sakai J, Brown MS, Goldstein JL. Regulated cleavage of sterol regulatory element binding proteins requires sequences on both sides of the endoplasmic reticulum membrane. J Biol Chem 271:10379-10384, 1996.
17. Yang T, Espenshade PJ, Wright ME, Yabe D, Gong Y, Aebersold R, Goldstein JL, Brown MS. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110:489-500, 2002.
18. Dobrosotskaya IY, Goldstein JL, Brown MS, Rawson RB. Reconstitution of sterol-regulated endoplasmic reticulum-to-Golgi transport of SREBP-2 in insect cells by co-expression of mammalian SCAP and Insigs. J Biol Chem 278:35837-35843, 2003.
19. Shimano H. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 40:439-452, 2001.
20. Horton JD, Shimomura I, Brown MS, Hammer RE, Goldstein JL, Shimano H. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J Clin Invest 101:2331-2339, 1998.
21. Kirby JL, Yang L, Labus JC, Lye RJ, Hsia N, Day R, Cornwall GA, Hinton BT. Characterization of epididymal epithelial cell-specific gene promoters by in vivo electroporation. Biol Reprod 71:613-619, 2004.
22. Ike A, Ohta H, Onishi M, Iguchi N, Nishimune Y, Nozaki M. Transient expression analysis of the mouse ornithie decarboxylase antizyme haploid-specific promoter using in vivo electroporation. FEBS Lett 559:159-164, 2004.
23. Widlak W, Scieglinska D, Vydra N, Malusecka E, Krawczyk Z. In vivo electroporation of the testis versus transgenic mice model in functional studies of spermatocyte-specific hst70 gene promoter: a comparative study. Mol Reprod Dev 65:382-388, 2003.
24. Riquet FB, Rodriguez M, Guigal N, Dromaint S, Naime I, Boutin JA, Galizzi JP. In vivo characterisation of the human UCP3 gene minimal promoter in mice tibialis anterior muscles. Biochem Biophys Res Commun 311:583-591, 2003.
25. Heller R, Jaroszeski M, Atkin A, Moradpour D, Gilbert R, Wands J, Nicolau C. In vivo gene electroinjection and expression in rat liver. FEBS Lett 389:225-228, 1996.
26. Fujishiro K, Fukui Y, Sato O, Kawabe K, Seto K, Motojima K. Analysis of tissue-specific and PPARalpha-dependent induction of FABP gene expression in the mouse liver by an in vivo DNA electroporation method. Mol Cell Biochem 239:165-172, 2002.
27. Muramatsu T, Ito N, Tamaoki N, Oda H, Park HM. In vivo gene electroporation confers nutritionally-regulated foreign gene expression in the liver. Int J Mol Med 7:61-66, 2001.
28. Latasa MJ, Griffin MJ, Moon YS, Kang C, Sul HS. Occupancy and function of the -150 sterol regulatory element and -65 E-box in nutritional regulation of the fatty acid synthase gene in living animals. Mol Cell Biol 23:5896-5907, 2003.
29. Haviv YS, van Houdt WJ, Lu B, Curiel DT, Zhu ZB. Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter. Mol Cancer Ther 3:687-691, 2004.
30. Al-Dosari MS, Knapp JE, Liu D. Activation of human CYP2C9 promoter and regulation by CAR and PXR in mouse liver. Mol Pharm 3:322-328, 2006.
31. Heller LC, Ugen K, Heller R. Electroporation for targeted gene transfer. Expert Opin Drug Deliv 2:255-268, 2005.
32. Heller R. Delivery of plasmid DNA using in vivo electroporation. Preclinica 1:198-208, 2003.
33. Lagor WR, de Groh ED, Ness GC. Diabetes alters the occupancy of the hepatic 3-hydroxy-3-methylglutaryl-CoA reductase promoter. J Biol Chem 280:36601-36608, 2005.
34. Ness GC, Zhao Z. Thyroid hormone rapidly induces hepatic LDL receptor mRNA levels in hypophysectomized rats. Arch Biochem Biophys 315:199-202, 1994.
35. Liscum L, Luskey KL, Chin DJ, Ho YK, Goldstein JL, Brown MS. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and its mRNA in rat liver as studied with a monoclonal antibody and a cDNA probe. J Biol Chem 258:8450-8455, 1983.
36. Ness GC, Holland RC, Lopez D. Selective compensatory induction of hepatic HMG-CoA reductase in response to inhibition of cholesterol absorption. Exp Biol Med (Maywood) 231:559-565, 2006.
37. Osborne AR, Pollock VV, Lagor WR, Ness GC. Identification of insulin-responsive regions in the HMG-CoA reductase promoter. Biochem Biophys Res Commun 318:814-818, 2004.
38. Ngo TT, Bennett MK, Bourgeois AL, Toth JI, Osborne TF. A role for cyclic AMP response element-binding protein (CREB) but not the highly similar ATF-2 protein in sterol regulation of the promoter for 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Biol Chem 277:33901-33905, 2002.
39. Ness GC, Eales S, Lopez D, Zhao Z. Regulation of 3-hydroxy-3- methylglutaryl coenzyme A reductase gene expression by sterols and nonsterols in rat liver. Arch Biochem Biophys 308:420-425, 1994.
40. Lopez D, Chambers CM, Ness GC. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors unmask cryptic regulatory mechanisms. Arch Biochem Biophys 343:118-122, 1997.
41. Kuriyama H, Liang G, Engelking LJ, Horton JD, Goldstein JL, Brown MS. Compensatory increase in fatty acid synthesis in adipose tissue of mice with conditional deficiency of SCAP in liver. Cell Metab 1:41-51, 2005.
42. Shimano H, Shimomura I, Hammer RE, Herz J, Goldstein JL, Brown MS, Horton JD. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. J Clin Invest 100:2115-2124, 1997.
43. Ohashi K, Osuga J, Tozawa R, Kitamine T, Yagyu H, Sekiya M, Tomita S, Okazaki H, Tamura Y, Yahagi N, Iizuka Y, Harada K, Gotoda T, Shimano H, Yamada N, Ishibashi S. Early embryonic lethality caused by targeted disruption of the 3-hydroxy-3-methylglutaryl-CoA reductase gene. J Biol Chem 278:42936-42941, 2003.
44. Reynolds GA, Basu SK, Osborne TF, Chin DJ, Gil G, Brown MS, Goldstein JL, Luskey KL. HMG CoA reductase: a negatively regulated gene with unusual promoter and 59 untranslated regions. Cell 38:275-285, 1984.
45. Nakanishi M, Goldstein JL, Brown MS. Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase: mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme. J Biol Chem 263:8929-8937, 1988.
46. Chambers CM, Ness GC. Dietary cholesterol regulates hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in rats primarily at the level of translation. Arch Biochem Biophys 354: 317-322, 1998.
47. Korn BS, Shimomura I, Bashmakov Y, Hammer RE, Horton JD, Goldstein JL, Brown MS. Blunted feedback suppression of SREBP processing by dietary cholesterol in transgenic mice expressing sterol-resistant SCAP(D443N). J Clin Invest 102:2050-2060, 1998.
48. Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest 98:1575-1584, 1996.